These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1425 related items for PubMed ID: 12421111

  • 1. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 2. Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    BioDrugs; 2003; 17(2):139-45. PubMed ID: 12641492
    [Abstract] [Full Text] [Related]

  • 3. Etanercept: a review of its use in rheumatoid arthritis.
    Jarvis B, Faulds D.
    Drugs; 1999 Jun; 57(6):945-66. PubMed ID: 10400407
    [Abstract] [Full Text] [Related]

  • 4. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [Abstract] [Full Text] [Related]

  • 5. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [Abstract] [Full Text] [Related]

  • 6. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD004525. PubMed ID: 23728649
    [Abstract] [Full Text] [Related]

  • 7. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M, TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.
    Lancet; 2004 Feb 28; 363(9410):675-81. PubMed ID: 15001324
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.
    Drug Saf; 2002 Feb 28; 25(3):173-97. PubMed ID: 11945114
    [Abstract] [Full Text] [Related]

  • 10. Psoriatic arthritis: the role of TNF inhibition and the effect of its inhibition with etanercept.
    Mease P.
    Clin Exp Rheumatol; 2002 Feb 28; 20(6 Suppl 28):S116-21. PubMed ID: 12463460
    [Abstract] [Full Text] [Related]

  • 11. Etanercept: a review of its use in the management of rheumatoid arthritis.
    Dhillon S, Lyseng-Williamson KA, Scott LJ.
    Drugs; 2007 Feb 28; 67(8):1211-41. PubMed ID: 17521223
    [Abstract] [Full Text] [Related]

  • 12. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
    Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ.
    Lancet; 2000 Jul 29; 356(9227):385-90. PubMed ID: 10972371
    [Abstract] [Full Text] [Related]

  • 13. Adalimumab: a review of its use in rheumatoid arthritis.
    Bang LM, Keating GM.
    BioDrugs; 2004 Jul 29; 18(2):121-39. PubMed ID: 15046527
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL, Chou SJ, Chen DY, Chen YH, Hsieh TY, Young M.
    J Formos Med Assoc; 2004 Aug 29; 103(8):618-23. PubMed ID: 15340661
    [Abstract] [Full Text] [Related]

  • 15. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 29; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 16. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
    Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Dunn M, Tsuji W.
    J Rheumatol; 2006 Apr 29; 33(4):712-21. PubMed ID: 16463435
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 29; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 18. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU, GO-AFTER study investigators.
    Lancet; 2009 Jul 18; 374(9685):210-21. PubMed ID: 19560810
    [Abstract] [Full Text] [Related]

  • 19. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B.
    Lancet; 2013 Mar 16; 381(9870):918-29. PubMed ID: 23332236
    [Abstract] [Full Text] [Related]

  • 20. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F.
    Recenti Prog Med; 2003 Sep 16; 94(9):361-79. PubMed ID: 12942798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.